Skip to main content
Erschienen in: Neurological Sciences 3/2016

01.03.2016 | Original Article

Transcranial sonography in movement disorders: an interesting tool for diagnostic perspectives

verfasst von: E. Sanzaro, F. Iemolo

Erschienen in: Neurological Sciences | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Transcranial sonography has become an important tool for the diagnosis of various movement disorders. In most patients with idiopathic Parkinson disease, a markedly hyperechogenic substantia nigra (SN) was detected on at least one side. We have highlighted the sonographic features that might help the differential diagnosis of PD and other movement disorders. Our investigation involved 30 patients (age 45–85 years) with idiopathic Parkinson disease, 2 multiple system atrophy, 3 progressive supranuclear palsy and 2 patients with restless legs syndrome. In accordance with several previous studies, we detected hyperechogenicity of the SN by TCS in 90 % of patients with idiopathic Parkinson disease. Subjects with a marked severity disease had a larger extent of the hyperechogenic SN signal. All progressive supranuclear palsy patients had an enlarged third ventricle and, in two cases, we observed the presence of hyperechoic areas in the lentiform nucleus. This last ultrasonographic feature was also seen in our patients with multiple system atrophy. TCS abnormalities of the SN, midbrain raphe and basal ganglia are characteristics of several movement and affective disorders. These features are less easily detected by other techniques, such as CT and MRI, which enable the exclusion of structural lesions, such as tumours and multi-infarct disease, because the physical principle differs from other imaging methods.
Literatur
1.
Zurück zum Zitat Behnke S, Berg D, Naumann M, Becker G (2005) Differentiation of Parkinson’s disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry 76:423–425CrossRefPubMedPubMedCentral Behnke S, Berg D, Naumann M, Becker G (2005) Differentiation of Parkinson’s disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry 76:423–425CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Berg D, Godau J, Walter U (2008) Transcranial sonography in movement disorders. Lancet Neurol 7:1044–1055CrossRefPubMed Berg D, Godau J, Walter U (2008) Transcranial sonography in movement disorders. Lancet Neurol 7:1044–1055CrossRefPubMed
3.
Zurück zum Zitat Kolevski G, Petrov I, Petrova V (2007) Transcranial sonography in the evaluation of Parkinson disease. J Ultrasound Med 26:509–512PubMed Kolevski G, Petrov I, Petrova V (2007) Transcranial sonography in the evaluation of Parkinson disease. J Ultrasound Med 26:509–512PubMed
4.
Zurück zum Zitat Gaenslen A et al (2008) The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson’s disease: a prospective blinded study. Lancet Neurol 7:417–424CrossRefPubMed Gaenslen A et al (2008) The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson’s disease: a prospective blinded study. Lancet Neurol 7:417–424CrossRefPubMed
5.
Zurück zum Zitat Martin WR, Wieler M, Gee M (2008) Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 70:1411–1417CrossRefPubMed Martin WR, Wieler M, Gee M (2008) Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 70:1411–1417CrossRefPubMed
6.
Zurück zum Zitat Zecca L, Berg D, Arzberger T et al (2005) In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage. Mov Disord 20(10):1278–1285CrossRefPubMed Zecca L, Berg D, Arzberger T et al (2005) In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage. Mov Disord 20(10):1278–1285CrossRefPubMed
7.
Zurück zum Zitat Michell AW, Lewis SJG, Foltynie T, Barker RA (2004) Biomarkers and Parkinson’s disease. Brain 127:1693–1705CrossRefPubMed Michell AW, Lewis SJG, Foltynie T, Barker RA (2004) Biomarkers and Parkinson’s disease. Brain 127:1693–1705CrossRefPubMed
8.
Zurück zum Zitat Spiegel J et al (2006) Transcranial sonography and [123I] FP-CIT SPECT disclose complementary aspects of Parkinson’s disease. Brain 129:1188–1193CrossRefPubMed Spiegel J et al (2006) Transcranial sonography and [123I] FP-CIT SPECT disclose complementary aspects of Parkinson’s disease. Brain 129:1188–1193CrossRefPubMed
9.
Zurück zum Zitat Sanzaro E, Iemolo F, Duro G, Malferrari G (2014) A new assessment tool for Parkinson disease. The nigral lesion load obtained by transcranial sonography. J Ultrasound Med 33:1635–1640CrossRefPubMed Sanzaro E, Iemolo F, Duro G, Malferrari G (2014) A new assessment tool for Parkinson disease. The nigral lesion load obtained by transcranial sonography. J Ultrasound Med 33:1635–1640CrossRefPubMed
10.
Zurück zum Zitat Rocchi L, Niccolini F, Politis M (2015) Recent imaging advances in neurology. J Neurol 262(9):2182–2194CrossRefPubMed Rocchi L, Niccolini F, Politis M (2015) Recent imaging advances in neurology. J Neurol 262(9):2182–2194CrossRefPubMed
Metadaten
Titel
Transcranial sonography in movement disorders: an interesting tool for diagnostic perspectives
verfasst von
E. Sanzaro
F. Iemolo
Publikationsdatum
01.03.2016
Verlag
Springer Milan
Erschienen in
Neurological Sciences / Ausgabe 3/2016
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-015-2424-6

Weitere Artikel der Ausgabe 3/2016

Neurological Sciences 3/2016 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.